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Abstract
Wound healing involves a number of physiologic mechanisms including coagulation,
inflammation, formation of granulation tissue, and tissue remodeling. Coagulation with robust
thrombin generation leading to fibrin formation is necessary for wound healing. It is less clear if
there is a requirement for ongoing coagulation to support tissue remodeling. We have studied
wound healing in mice with defects in both the initiation (low tissue factor) and propagation
(hemophilia B) phases. In hemophilia B mice, dermal wound healing is delayed; this delay is
associated with bleeding into the granulation tissue. Mice can be treated with replacement therapy
(factor IX) or bypassing agents (factor VIIa) to restore thrombin generation. If treated just prior to
wound placement, mice will have normal hemostasis in the first day of wound healing. As the
therapeutic agents clear, the mice will revert to hemophilic state. If the primary role of coagulation
in wound healing is to provide a stable platelet/fibrin plug that is loaded with thrombin, then
treating hemophilic animals just prior to wound placement should restore normal wound healing.
The results from this study did not support that hypothesis. Instead the results show that restoring
thrombin generation only at the time of wound placement did not improve the delayed wound
healing. In preliminary studies on low tissue factor mice, there also appears to be a delay in wound
healing with evidence of bleeding into the granulation tissue. The current data suggests that
ongoing coagulation function needs to be maintained to support a normal wound healing process.
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Phases of wound healing
The term wound healing has been used in a variety of animal models of incisional and
excisional injuries to skin, muscle, and corneas; the term has also been used to describe
experiments carried out in tissue culture models. In that setting it refers to the migration of
cells to cover a denuded portion of a culture well. In this paper we use the term to mean
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reepithelialization of an excisional skin wound. This model does not attempt to be a model
of joint injury; for models of hemophilic joint injury see [1,2]. Rather, this skin injury model
has allowed us to examine the role of coagulation in some aspects of wound healing.
Wound healing is a process that involves a number of physiologic mechanisms (figure 1A)
including coagulation, inflammation, formation of granulation tissue, and tissue remodeling
[3,4]. Coagulation leading to thrombin generation is an immediate response to the initial
injury. Thrombin generation results in aggregation of a platelet and fibrin mass that fills and
stabilizes the wound preventing further blood loss. There is also a very rapid response by
neutrophils and macrophages migrating along the fibrin matrix to prevent infection of the
wound and clean up invading organisms and tissue debris. Subsequently fibroblasts crawl
along the fibrin matrix and begin to form connective tissue, and endothelial sprouts begin
revacularization of the site, transitioning the wound into granulation tissue. During all of
this, the epithelial cells migrate and proliferate across the surface of the wound, displacing
the scab, until the wound is closed (reepithelialized).
Role of fibrin structure
Having an appropriate fibrin structure is necessary for a number of the subsequent healing
steps [5]. Mice that lacked fibrinogen could form wounds that would reepithelialize, but the
initial wound strength was reduced and long term cellular migration within wound fields
was altered [6]. Mice which have a defect in fibrin stabilization (factor XIII knockout) had
defects in wound healing with a delay in reepithelialization [7]. This is consistent with the
observation that fibroblast proliferation as well as expression of growth factors and
interleukins is altered by changes in fibrin structure [8]. Further evidence for the importance
of fibrin structure comes from studies in mice with defects in fibrin removal (plasminogen
deficiency). In these mice the reepithelialization was significantly delayed, with as many as
a third of the mice having open wounds 6 weeks after wounding [9].
Among the determinants that influence fibrin structure is the rate and pattern of thrombin
generation [10]. Since fibrin sequesters thrombin, it is easy to envision a model in which
thrombin generated initially during the coagulation phase could have long term effects on
wound healing. And it is not uncommon to find in the literature a discussion of the wound
healing process similar to that shown in figure 1 where coagulation is described as being
critical only for the initial formation of the platelet/fibrin plug.
Roles of thrombin
While thrombin generation is required for fibrin formation, thrombin and other coagulation
proteins have functions beyond hemostasis (for reviews see [11,12]). Thrombin influences
wound healing by acting as a chemotactic agent and a mitogenic agent for macrophage
influx as well as promoting angiogenesis [13–15]. Thrombin can cleave the protease
activated receptor 1 (PAR1) [16] and it seems reasonable that thrombin cleavage of PAR1
might play a role in wound healing. However, a study on PAR1 knockout mice showed no
changes in time to closure of open wounds, tensile strength of healed incisional wounds, or
wound histology [17]. A later, unpublished study did note some differences in healing of an
excisional wound in PAR1 knockout mice including reductions in wound contraction and
reduced leukocyte infiltration [18]. And hydrogel dressings impregnated with the PAR1
agonist peptide promoted more rapid closure of excisional wounds than dressing alone [19].
Wound healing model
To examine the role of coagulation and thrombin generation in both the initial and the
overall process of wound healing, we initiated studies on hemophilia B mice [20]. These
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mice have a clear bleeding defect in a tail transection model as well as in the Whinna
saphenous vein injury model [21]. To study wound healing, a single 3-mm biopsy punch
wound was placed on the back of each animal [22]. The wound was through the skin down
to, but not into, the muscle. In both wild type and hemophilic animals there was evidence of
some fibrin deposition in the wound bed indicating that some level of thrombin had been
generated. Immediately after wounding neither wild type nor hemophilic wounds
consistently showed evidence of bleeding. However, as expected, the extent of fibrin
deposition (as determined by immunohistochemical staining) was dramatically reduced in
the hemophilic wounds. Of interest was the finding that fibrin staining extended well into
the edematous and inflamed tissue surrounding the wound site, and was not confined to the
injury site in wild type mice. However, in hemophilic mice fibrin was only found at the
edges of the tissue defect adjacent to the remaining epithelium. This localization is likely
because epithelial cells express high level of tissue factor and are able to support some
thrombin generation in the absence of factor VIII or IX. Consistent with defective thrombin
and fibrin formation, wounds placed on hemophilic animals typically showed signs of
bleeding (Figure 2) by 24 hours.
Wounds on hemophilic animals healed more slowly than wounds on wild type animals [22].
Some wild type animals had wounds that were reepithelialized by day 8 after wounding,
with all wild type animals healed by day 10. By contrast no wounds on hemophilia B mice
were healed until day 10; many were healed by day 12, and a few animals required up to 15
days for healing. This established that the coagulation defect in hemophilia is associated
with delayed wound healing.
Role of thrombin beyond the initial hemostasis
Thrombin generation can be increased in hemophilia B mice by treatment with replacement
therapy (factor IX) or treatment with bypassing agents (factor VIIa). Mice treated just prior
to wound placement will have increased thrombin generation during the time the wound is
placed; subsequently the animals will return to hemophilic levels. So, if the primary role of
coagulation in wound healing is to provide a stable platelet/fibrin plug that is loaded with
thrombin, then treating hemophilic animals just prior to wound placement should fully
restore normal wound healing.
Studies on hemophilia B mice treated just prior to wounding did not support this hypothesis
[23]. Pretreatment with either factor IX or factor VIIa at doses that completely corrected
bleeding the in saphenous vein injury model did not shorten the time required for
reepithelialization in hemophilic animals. Treatment did however have some effect on the
histologic features of the wound. In untreated hemophilia B animals macrophage influx is
delayed and decreased. Treated mice had a more robust early macrophage influx that was
similar to wild type mice. This suggests that chemotactic signals generated during the initial
coagulation phase are important for macrophage influx. However, in both treated and
untreated hemophilia B mice, macrophage influx persisted much longer than in wild type
animals. The macrophages stained for iron suggesting that there was bleeding into the
granulation tissue. In wild type animals iron staining was seen early in the granulation tissue
with the iron being carried off by the macrophages into the deep tissues and the draining
lymph nodes. In both treated and untreated hemophilic animals, the iron staining persisted at
a high level well past the point where the wounds were reepithelialized. This data points to
ongoing bleeding into the granulation tissue and suggests that coagulation is necessary to
limit bleeding into the granulation tissue during tissue remodeling.
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Role of tissue factor
Tissue factor, in addition to being the primary initiator of coagulation, can play a role in a
number of mechanisms that may be important in wound healing (for a review see [24]). In
diabetic mice, tissue factor is not upregulated in excisional wounds to the same extent as in
wild type mice [25]. When somatic gene transfer was used to increase tissue factor levels in
the wounds of these diabetic mice: fibrin deposition in the wound bed increased; more tissue
factor was seen in the migrating epidermal tips; and wound healing time was restored to
normal [25]. These results suggest that both coagulant and non-coagulant functions of tissue
factor might be important in the wound healing process.
In examining the granulation tissue of dermal wounds, one striking feature is the lack of
staining for tissue factor [26]. Tissue factor staining can be observed in the surrounding
dermal tissue and tissue factor is strongly expressed at the leading edge of the epithelial
layer that is closing the wound. However, there is little or no staining for tissue factor in the
granulation tissue, nor is it present around the newly formed angiogenic vessels. In addition,
tissue factor that is normally present on the pericytes around blood vessels disappears in the
area of inflammation surrounding the wound. Tissue factor expression does not completely
reappear for several days (with delayed reappearance in hemophilic animals). This lack of
tissue factor may account for the propensity of granulation tissue to bleed, and even in wild
type animals some extravasated red blood cells can be observed in the granulation tissue. In
hemophilic animals this bleeding tendency is exaggerated with red blood cells easily visible
in the granulation tissue.
To further examine the role of tissue factor in wound healing, preliminary studies have
begun with low tissue factor mice [27]. These mice express human tissue factor at roughly
1% of the levels of tissue factor seen in wild type mice. The mice develop normally and the
majority of the mice do not have an obvious bleeding diathesis in the first 3 months. As with
hemophilic animals, wounds placed on low tissue factor mice did not immediately bleed.
However during healing some but not all animals showed signs of bleeding in the wound
bed (figure 2). Wound healing was delayed by at least one day in the limited number of
animals studied. Extravasated red blood cells could be observed in the granulation tissue
suggesting ongoing bleeding in these animals.
Summary
Taken together, this data and published data suggests that coagulation function is required in
the immediate response to wounding and that robust thrombin generation leading to fibrin
formation is a necessary component for healthy wound healing. But this data also suggests
that ongoing coagulation function needs to be maintained for an extended period to support
a normal wound healing process (figure 1B). Whether this coagulation function is only
required for hemostasis or whether modulation of signaling, possibly through through
activation of PAR receptors including PAR-1, is also a key component is the subject of our
ongoing investigations.
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Classical view of cells involved in different stages of wound healing. A. This figure is
derived from figure 1 of Witte and Barbul [3]. The various stages of healing are shown
associated with days in which that stage occurs. The relative involvement of various cell
types is plotted against the days in which those cell types appear. B. TVisually presents the
hypothesis that coagulation plays a significant role in the wound healing process for longer
than just the period of initial hemostasis required to form a fibrin/platelet plug.
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Day 3 wounds. Wounds in wild type (WT) animals did not generally show signs of bleeding
in the wounds. Wounds placed on hemophilia B (Hem B) animals often showed clear
evidence of bleeding into the wound bed. In preliminary studies, some, but not all, low
tissue factor (low TF) mice showed evidence of some bleeding into the wound beds.
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